Literature DB >> 25307057

A three-dimensional human neural cell culture model of Alzheimer's disease.

Se Hoon Choi1, Young Hye Kim2, Matthias Hebisch3, Christopher Sliwinski4, Seungkyu Lee5, Carla D'Avanzo4, Hechao Chen4, Basavaraj Hooli4, Caroline Asselin4, Julien Muffat6, Justin B Klee4, Can Zhang4, Brian J Wainger5, Michael Peitz7, Dora M Kovacs4, Clifford J Woolf5, Steven L Wagner8, Rudolph E Tanzi4, Doo Yeon Kim4.   

Abstract

Alzheimer's disease is the most common form of dementia, characterized by two pathological hallmarks: amyloid-β plaques and neurofibrillary tangles. The amyloid hypothesis of Alzheimer's disease posits that the excessive accumulation of amyloid-β peptide leads to neurofibrillary tangles composed of aggregated hyperphosphorylated tau. However, to date, no single disease model has serially linked these two pathological events using human neuronal cells. Mouse models with familial Alzheimer's disease (FAD) mutations exhibit amyloid-β-induced synaptic and memory deficits but they do not fully recapitulate other key pathological events of Alzheimer's disease, including distinct neurofibrillary tangle pathology. Human neurons derived from Alzheimer's disease patients have shown elevated levels of toxic amyloid-β species and phosphorylated tau but did not demonstrate amyloid-β plaques or neurofibrillary tangles. Here we report that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloid-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system. More importantly, the 3D-differentiated neuronal cells expressing FAD mutations exhibited high levels of detergent-resistant, silver-positive aggregates of phosphorylated tau in the soma and neurites, as well as filamentous tau, as detected by immunoelectron microscopy. Inhibition of amyloid-β generation with β- or γ-secretase inhibitors not only decreased amyloid-β pathology, but also attenuated tauopathy. We also found that glycogen synthase kinase 3 (GSK3) regulated amyloid-β-mediated tau phosphorylation. We have successfully recapitulated amyloid-β and tau pathology in a single 3D human neural cell culture system. Our unique strategy for recapitulating Alzheimer's disease pathology in a 3D neural cell culture model should also serve to facilitate the development of more precise human neural cell models of other neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25307057      PMCID: PMC4366007          DOI: 10.1038/nature13800

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  Protection of neurons derived from human neural progenitor cells by veratridine.

Authors:  Peter J Morgan; Stefanie Ortinau; Jana Frahm; Norman Krüger; Arndt Rolfs; Moritz J Frech
Journal:  Neuroreport       Date:  2009-08-26       Impact factor: 1.837

3.  Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

Authors:  P Cras; M Kawai; S Siedlak; P Mulvihill; P Gambetti; D Lowery; P Gonzalez-DeWhitt; B Greenberg; G Perry
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

4.  Use of excitatory amino acids to make axon-sparing lesions of hypothalamus.

Authors:  J V Nadler; D A Evenson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Modeling familial Alzheimer's disease with induced pluripotent stem cells.

Authors:  Takuya Yagi; Daisuke Ito; Yohei Okada; Wado Akamatsu; Yoshihiro Nihei; Takahito Yoshizaki; Shinya Yamanaka; Hideyuki Okano; Norihiro Suzuki
Journal:  Hum Mol Genet       Date:  2011-09-07       Impact factor: 6.150

Review 6.  Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

Authors:  Carl Julien; Alexis Bretteville; Emmanuel Planel
Journal:  Methods Mol Biol       Date:  2012

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

9.  1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.

Authors:  Conrad Kunick; Kathrin Lauenroth; Maryse Leost; Laurent Meijer; Thomas Lemcke
Journal:  Bioorg Med Chem Lett       Date:  2004-01-19       Impact factor: 2.823

10.  A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.

Authors:  Robert M Cohen; Kavon Rezai-Zadeh; Tara M Weitz; Altan Rentsendorj; David Gate; Inna Spivak; Yasmin Bholat; Vitaly Vasilevko; Charles G Glabe; Joshua J Breunig; Pasko Rakic; Hayk Davtyan; Michael G Agadjanyan; Vladimir Kepe; Jorge R Barrio; Serguei Bannykh; Christine A Szekely; Robert N Pechnick; Terrence Town
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

View more
  377 in total

1.  3D Printed Stem-Cell Derived Neural Progenitors Generate Spinal Cord Scaffolds.

Authors:  Daeha Joung; Vincent Truong; Colin C Neitzke; Shuang-Zhuang Guo; Patrick J Walsh; Joseph R Monat; Fanben Meng; Sung Hyun Park; James R Dutton; Ann M Parr; Michael C McAlpine
Journal:  Adv Funct Mater       Date:  2018-08-09       Impact factor: 18.808

2.  Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.

Authors:  Yingxia Liang; Frank Raven; Joseph F Ward; Sherri Zhen; Siyi Zhang; Haoqi Sun; Sean J Miller; Se Hoon Choi; Rudolph E Tanzi; Can Zhang
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Three-Dimensional Neural Spheroid Culture: An In Vitro Model for Cortical Studies.

Authors:  Yu-Ting L Dingle; Molly E Boutin; Anda M Chirila; Liane L Livi; Nicholas R Labriola; Lorin M Jakubek; Jeffrey R Morgan; Eric M Darling; Julie A Kauer; Diane Hoffman-Kim
Journal:  Tissue Eng Part C Methods       Date:  2015-10-06       Impact factor: 3.056

4.  A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise.

Authors:  Yewande Pearse; Michelina Iacovino
Journal:  Med Res Arch       Date:  2020-02-21

Review 5.  Assessing drug response in engineered brain microenvironments.

Authors:  Kinsley M Tate; Jennifer M Munson
Journal:  Brain Res Bull       Date:  2019-05-01       Impact factor: 4.077

Review 6.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

Review 7.  Human astrocytes are distinct contributors to the complexity of synaptic function.

Authors:  Robert Krencik; Jessy V van Asperen; Erik M Ullian
Journal:  Brain Res Bull       Date:  2016-08-25       Impact factor: 4.077

Review 8.  Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.

Authors:  Alexandra Grubman; Katja M Kanninen; Tarja Malm
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

Review 9.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

10.  Biomimetic on-a-chip platforms for studying cancer metastasis.

Authors:  Esak Lee; H-H Greco Song; Christopher S Chen
Journal:  Curr Opin Chem Eng       Date:  2015-12-18       Impact factor: 5.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.